Development

Articles

Presspart will still be responsible for the manufacturing of the Sunriser device.

Hovione and H&T Presspart Extend Partnership for Dry Powder Inhalation Formulation Delivery 

Editor of Pharmaceutical Technology Europe

Advancements in therapeutic modalities are necessitating change in drug delivery to help negate some of the expense of development and manufacturing.

Influencing Change in Drug Delivery

Grant Playter is the Assistant Editor for 

Polyplus’ LipidBrick is designed to expand the scope of lipid nanoparticle formulation usage in mRNA therapeutics and vaccine development.

Polyplus Introduces Novel LNP Formulation for Use in mRNA Therapeutics

Feliza Mirasol is the science editor for 

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.

Catalent Licenses Bhami Research Laboratory Technology for Biologics Formulation Development

Particle engineering can be a resourceful tool to advance drug candidates by offering drug delivery innovation. 

A Deep Dive into Particle Engineering as a Drug Delivery Tool

Companies need to consider and address formulation challenges to employ a successful reformulation strategy.

Considerations for a Successful Reformulation Strategy

There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.

Reformulating Success

Meg Rivers is the former senior editor for 

Research into oncolytic viruses potentiated by stem cells shows promise for treating cancer. 

Treating Cancer with Oncolytic Viruses

Scott Ripley is the general manager, nucleic acid, for Cytiva.

Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.

Accelerating the Development of mRNA Therapeutics

Hanna Jankevics Jones, PhD, is a pharmaceutical segment marketing manager at Malvern Panalytical.

Natalia Markova, PhD, is a pharmaceutical segment marketing manager at Malvern Panalytical.

Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.